These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12514422)

  • 21. When to start, when to STI (or, groping for the golden moment).
    Mascolini M
    IAPAC Mon; 2001 Apr; 7(4):114-7, 120-31. PubMed ID: 11700605
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group.
    Rezza G; Lepri AC; d'Arminio Monforte A; Pezzotti P; Castelli F; Dianzani F; Lazzarin A; De Luca A; Arlotti M; Leoncini F; Manconi PE; Rizzardini G; Minoli L; Poggio A; Ippolito G; Phillips AN; Moroni M
    J Acquir Immune Defic Syndr; 2000 Sep; 25(1):56-62. PubMed ID: 11064505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of antiretroviral therapy on HIV shedding in semen.
    Barroso PF; Schechter M; Gupta P; Melo MF; Vieira M; Murta FC; Souza Y; Harrison LH
    Ann Intern Med; 2000 Aug; 133(4):280-4. PubMed ID: 10929169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral therapy in human immunodeficiency virus-infected individuals.
    Spooner KM
    Adv Intern Med; 1998; 43():373-402. PubMed ID: 9506188
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of first line therapy including efavirenz and two nucleoside reverse transcriptase inhibitors in HIV-infected children.
    Funk MB; Notheis G; Schuster T; Elanjkal Z; von Hentig N; Stürmer M; Linde R; Dunsch D; Königs C; Wintergerst U; Kreuz W
    Eur J Med Res; 2005 Dec; 10(12):503-8. PubMed ID: 16356864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.
    Pereira AS; Kashuba AD; Fiscus SA; Hall JE; Tidwell RR; Troiani L; Dunn JA; Eron JJ; Cohen MS
    J Infect Dis; 1999 Dec; 180(6):2039-43. PubMed ID: 10558966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
    Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
    JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010.
    Gilleece Y; Chadwick DR; Breuer J; Hawkins D; Smit E; McCrae LX; Pillay D; Smith N; Anderson J;
    HIV Med; 2010 Nov; 11(10):611-9. PubMed ID: 20961377
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of a population simulation model for HIV monotherapy virological outcomes using lamivudine.
    Hurwitz SJ; Asif G; Schinazi RF
    Antivir Chem Chemother; 2007; 18(6):329-41. PubMed ID: 18320937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
    Madelain V; Le MP; Champenois K; Charpentier C; Landman R; Joly V; Yeni P; Descamps D; Yazdanpanah Y; Peytavin G
    J Antimicrob Chemother; 2017 Apr; 72(4):1137-1146. PubMed ID: 28065890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl.
    Mussini C; Bugarini R; Perno CF; Antinori A; Borghi V; Bertoli A; D'Arrigo R; Bedini A; Mongiardo N; Cossarizza A; Esposito R
    AIDS; 2002 Jul; 16(11):1551-4. PubMed ID: 12131194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why are the decay rates in plasma HIV-1 different for different treatments and in different patient populations?
    Wu H; Ding AA; De Gruttola V
    AIDS; 1999 Feb; 13(3):429-30. PubMed ID: 10199240
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.
    Kwara A; Delong A; Rezk N; Hogan J; Burtwell H; Chapman S; Moreira CC; Kurpewski J; Ingersoll J; Caliendo AM; Kashuba A; Cu-Uvin S
    Clin Infect Dis; 2008 Mar; 46(5):719-25. PubMed ID: 18220480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The HIV-positive child].
    Castello MA; Catania N; Ajassa C
    Recenti Prog Med; 2000 Feb; 91(2):59-62. PubMed ID: 10748647
    [No Abstract]   [Full Text] [Related]  

  • 35. The church of viral suppression.
    Huff B
    GMHC Treat Issues; 2005; 19(9-11):1-9. PubMed ID: 16541505
    [No Abstract]   [Full Text] [Related]  

  • 36. Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen.
    Yilmaz A; Ståhle L; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
    Scand J Infect Dis; 2004; 36(11-12):823-8. PubMed ID: 15764168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of HIV despite the discontinuation of antiretroviral therapy.
    Lisziewicz J; Rosenberg E; Lieberman J; Jessen H; Lopalco L; Siliciano R; Walker B; Lori F
    N Engl J Med; 1999 May; 340(21):1683-4. PubMed ID: 10348681
    [No Abstract]   [Full Text] [Related]  

  • 38. [Viral loads in pediatric HIV patients with antiretroviral treatment].
    Porto-Espinoza L; Moronta R; Cuadra-Sánchez C; Callejas-Valero D; Costa-León L; Monsalve-Castillo F; Bernardoni C; Estévez J
    Rev Med Chil; 2008 Aug; 136(8):1021-6. PubMed ID: 18949186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposure.
    Kimulwo MJ; Okendo J; Aman RA; Ogutu BR; Kokwaro GO; Ochieng DJ; Muigai AW; Oloo FA; Ochieng W
    PLoS One; 2017; 12(2):e0172960. PubMed ID: 28235021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania.
    Sungi SS; Ngaimisi E; Ulenga N; Sasi P; Mugusi S
    BMC Pharmacol Toxicol; 2018 Oct; 19(1):66. PubMed ID: 30352627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.